Modelling the growth of a polymer micro-tip on an optical fiber end

Manufacturing end-of-fiber optical components able to realize optical functions ranging from a simple lens to more complex functions such as mode selective components is a decisive but \emph{a priori} complex task owing to the fiber core dimensions. Effective low cost methods allowing to grow polymer components by free-radical photopolymerization using the light coming out of the fiber have recently been reported. A novel phenomenological model of the photopolymerization process underlying is here given and used to simulate the polymer component growth in a three dimensional time-resolved manner. The simulations results are thus used to understand and optimize the component growth conditions, focusing particularly on the role of oxygen either present in the atmosphere or dissolved in the solution

Mapping the Electromagnetic Near-Field Enhancements of Gold Nanocubes

International audienceWe imaged and quantitatively characterized electromagnetic hot spots near the surfaces of plasmon resonant gold nanocubes. The strongest fields are localized at the nanocube corners as compared to those on the sides. The near-field enhancement on the surface of the cube was imaged as a function of incident polarization, leading to information on the localization of fields on specific regions on the surface. We found that the field intensity drops dramatically when the nanocube corner is slightly tilted with respect to the incident laser polarization. This dramatic dependence on angle was verified by electrodynamics simulations. These results will enable the use of gold nanocubes in field enhancement applications and refractive-index sensing

Two-photon photopolymerization directly initiated by spiropyran photochromic molecules

Here, we report the ability of spiropyrans to initiate two-photon polymerization (TPP) for the first time in the literature. The comparison and synergies between the spiropyran photochromic molecule of interest, namely 6-nitro-BIPS, and well-known photoinitiators of radical photopolymerization have been studied. The spiropyran (SPy) molecule can initiate TPP in the presence of trifunctional acrylic monomers and create true 3D structures. The comparison with Irgacure 819, a well-known Type-I photoinitiator, shows that SPy has a comparable capability for TPP. In addition, the combination of SPy with methyl diethanolamine increased the reactivity of both one- and two-photon polymerizations. In the last section, we discuss which SPy isomer is the active photochromic species capable of generating radicals for initiating two-photon polymerization

BMC Med

BACKGROUND: Overall survival (OS) is the gold standard endpoint to assess treatment efficacy in cancer clinical trials. In metastatic breast cancer (mBC), progression-free survival (PFS) is commonly used as an intermediate endpoint. Evidence remains scarce regarding the degree of association between PFS and OS. Our study aimed to describe the individual-level association between real-world PFS (rwPFS) and OS according to first-line treatment in female patients with mBC managed in real-world setting for each BC subtype (defined by status for both hormone-receptor [HR] expression and HER2 protein expression/gene amplification). METHODS: We extracted data from the ESME mBC database (NCT03275311) which gathers deidentified data from consecutive patients managed in 18 French Comprehensive Cancer Centers. Adult women diagnosed with mBC between 2008 and 2017 were included. Endpoints (PFS, OS) were described using the Kaplan-Meier method. Individual-level associations between rwPFS and OS were estimated using the Spearman's correlation coefficient. Analyses were conducted by tumor subtype. RESULTS: 20,033 women were eligible. Median age was 60.0 years. Median follow-up duration was 62.3 months. Median rwPFS ranged from 6.0 months (95% CI 5.8-6.2) for HR-/HER2 - subtype to 13.3 months (36% CI 12.7-14.3) for HR + /HER2 + subtype. Correlation coefficients were highly variable across subtypes and first-line (L1) treatments. Among patients with HR - /HER2 - mBC, correlation coefficients ranged from 0.73 to 0.81, suggesting a strong rwPFS/OS association. For HR + /HER2 + mBC patients, the individual-level associations were weak to strong with coefficients ranging from 0.33 to 0.43 for monotherapy and from 0.67 to 0.78 for combined therapies. CONCLUSIONS: Our study provides comprehensive information on individual-level association between rwPFS and OS for L1 treatments in mBC women managed in real-life practice. Our results could be used as a basis for future research dedicated to surrogate endpoint candidates

Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

Alcohol and tobacco consumption are closely correlated and published results on their association with breast cancer have not always allowed adequately for confounding between these exposures. Over 80% of the relevant information worldwide on alcohol and tobacco consumption and breast cancer were collated, checked and analysed centrally. Analyses included 58 515 women with invasive breast cancer and 95 067 controls from 53 studies. Relative risks of breast cancer were estimated, after stratifying by study, age, parity and, where appropriate, women's age when their first child was born and consumption of alcohol and tobacco. The average consumption of alcohol reported by controls from developed countries was 6.0 g per day, i.e. about half a unit/drink of alcohol per day, and was greater in ever-smokers than never-smokers, (8.4 g per day and 5.0 g per day, respectively). Compared with women who reported drinking no alcohol, the relative risk of breast cancer was 1.32 (1.19–1.45, P<0.00001) for an intake of 35–44 g per day alcohol, and 1.46 (1.33–1.61, P<0.00001) for ⩾45 g per day alcohol. The relative risk of breast cancer increased by 7.1% (95% CI 5.5–8.7%; P<0.00001) for each additional 10 g per day intake of alcohol, i.e. for each extra unit or drink of alcohol consumed on a daily basis. This increase was the same in ever-smokers and never-smokers (7.1% per 10 g per day, P<0.00001, in each group). By contrast, the relationship between smoking and breast cancer was substantially confounded by the effect of alcohol. When analyses were restricted to 22 255 women with breast cancer and 40 832 controls who reported drinking no alcohol, smoking was not associated with breast cancer (compared to never-smokers, relative risk for ever-smokers=1.03, 95% CI 0.98–1.07, and for current smokers=0.99, 0.92–1.05). The results for alcohol and for tobacco did not vary substantially across studies, study designs, or according to 15 personal characteristics of the women; nor were the findings materially confounded by any of these factors. If the observed relationship for alcohol is causal, these results suggest that about 4% of the breast cancers in developed countries are attributable to alcohol. In developing countries, where alcohol consumption among controls averaged only 0.4 g per day, alcohol would have a negligible effect on the incidence of breast cancer. In conclusion, smoking has little or no independent effect on the risk of developing breast cancer; the effect of alcohol on breast cancer needs to be interpreted in the context of its beneficial effects, in moderation, on cardiovascular disease and its harmful effects on cirrhosis and cancers of the mouth, larynx, oesophagus and liver

Advances in Nano-Optics

International audienc

Nanoplasmonique hybride basée sur l'anisotropie locale du milieu actif

International audienc

Plasmon-based nanophotopolymerization: nano-imaging, advanced hybrid plasmonics, nanophotochemistry

International audienc

Plasmonique Moléculaire

International audienc

Active Plasmons/molecules Interactions

International audienc